HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Mikulska Selected Research

M Mikulska Research Topics

Disease

8Infections
08/2021 - 12/2004
4Aspergillosis
01/2019 - 09/2009
4Neutropenia
07/2018 - 09/2009
4Sepsis (Septicemia)
06/2018 - 04/2009
3Neoplasms (Cancer)
01/2020 - 06/2012
3Opportunistic Infections (Opportunistic Infection)
12/2018 - 04/2009
3Communicable Diseases (Infectious Diseases)
06/2018 - 06/2012
3Hepatitis B
06/2018 - 10/2014
2Relapsing-Remitting Multiple Sclerosis
10/2020 - 11/2018
2Multiple Sclerosis
10/2020 - 11/2018
2Mycoses (Diseases, Fungus)
06/2012 - 04/2009
1COVID-19
07/2020
1Hematologic Diseases (Blood Diseases)
01/2020
1Mucormycosis
01/2019
1Hodgkin Disease (Hodgkin's Disease)
12/2018
1Visceral Leishmaniasis (Kala Azar)
12/2018
1Exanthema (Rash)
11/2018
1Serum Sickness
11/2018
1Arthralgia (Joint Pain)
11/2018
1Fever (Fevers)
11/2018
1Varicella Zoster Virus Infection
06/2018
1Lymphopenia (Lymphocytopenia)
06/2018
1Respiratory Tract Infections (Respiratory Tract Infection)
06/2018
1Hyper-IgM Immunodeficiency Syndrome (Hyper-IgM Syndrome)
06/2018
1Febrile Neutropenia
01/2018
1Hepatitis
12/2017
1Latent Infection
12/2017
1Lymphoma (Lymphomas)
12/2017
1Fever of Unknown Origin
03/2015
1Invasive Candidiasis
06/2012
1Cryptococcosis
06/2012
1Leukemia
06/2012
1Candidemia
03/2011
1Mucositis
12/2010
1Bacteremia
12/2010
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2009
1Unconsciousness (Loss of Consciousness)
04/2009
1Fungemia
04/2009

Drug/Important Bio-Agent (IBA)

4Alemtuzumab (Campath)FDA Link
10/2020 - 04/2009
3Anti-Bacterial Agents (Antibiotics)IBA
08/2021 - 02/2015
3Antiviral Agents (Antivirals)IBA
07/2020 - 12/2017
3Hepatitis B Surface Antigens (HBsAg)FDA Link
06/2018 - 10/2014
2Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
01/2020 - 07/2012
2FluoroquinolonesIBA
01/2020 - 07/2018
2Monoclonal AntibodiesIBA
11/2018 - 06/2018
2Surface Antigens (Surface Antigen)IBA
06/2018 - 06/2018
2galactomannanIBA
07/2012 - 06/2012
1AzolesIBA
01/2020
1Carbapenems (Carbapenem Antibiotics)IBA
01/2020
1isavuconazoleIBA
01/2019
1TriazolesIBA
01/2019
1Natalizumab (Tysabri)FDA Link
11/2018
1lucatumumabIBA
06/2018
1blinatumomabIBA
06/2018
1dacetuzumabIBA
06/2018
1elotuzumabIBA
06/2018
1mogamulizumabIBA
06/2018
1daratumumabIBA
06/2018
1inebilizumabIBA
06/2018
1Brentuximab VedotinIBA
06/2018
1Immunoglobulin G (IgG)IBA
06/2018
1Proteins (Proteins, Gene)FDA Link
12/2017
1DNA (Deoxyribonucleic Acid)IBA
12/2017
1DaptomycinFDA Link
02/2015
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2014
1GlucansIBA
06/2012
1Biomarkers (Surrogate Marker)IBA
06/2012
1Biological ProductsIBA
06/2012
1MannansIBA
06/2012
1Sodium Glutamate (Accent)IBA
06/2012
1polysaccharide-KIBA
03/2011
1Cephalosporins (Cephalosporin Antibiotics)IBA
12/2010
1VancomycinFDA LinkGeneric
12/2010
1SteroidsIBA
09/2009
1liposomal amphotericin BFDA Link
04/2009
1RNA (Ribonucleic Acid)IBA
12/2004

Therapy/Procedure

10Therapeutics
07/2020 - 04/2009
5Stem Cell Transplantation
10/2020 - 09/2009
2Drug Therapy (Chemotherapy)
12/2018 - 12/2017
2Catheters
06/2018 - 02/2015
2Biological Therapy
06/2018 - 06/2018
1Debridement
08/2021
1Urinary Catheters
01/2020
1Cell Transplantation
12/2018
1Intravenous Infusions
06/2018